NCT03275623.
Trial name or title | Management of sub‐clinical bacteriuria in pregnancy: a feasibility trial |
Methods | Randomised, open label; 2 parallel groups |
Participants | Pregnant women, without symptoms of urinary tract infection, with a low level of bacteria (less than 100,000 colony forming units/mL). Exclusion criteria include risk factors for complicated urinary tract infection, use of immunosuppressive drugs, abnormalities of the urinary tract, history of renal disease, and urine culture with > 100,000 CFU/mL of any organism. |
Interventions | Standard prenatal care plus either nitrofurantoin, cephalexin, or amoxicillin (choice determined by the physician) or no treatment |
Outcomes | Number of women with cystitis (defined as urine culture with > 100,000 CFU/mL); number of women with pyelonephritis (urine culture with > 100,000 CFU/mL with fever) |
Starting date | September 2017 |
Contact information | Akwugo A Eziefule, MD University of Texas Health Center at Houston Houston, Texas, USA 77030 Telephone 713‐500‐6421 Akwugo.A.Eziefule@uth.tmc.edu |
Notes | Follow‐up for the last patient enrolled is planned for February 2019 |